Bailey David R 4
4 · ORTHOPEDIATRICS CORP · Filed May 21, 2020
Insider Transaction Report
Form 4
Bailey David R
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−4,824$149,399→ 0 totalExercise: $30.97Exp: 2020-07-23→ Common Stock (4,824 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2021-08-03→ Common Stock (402 underlying) - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 98,368 total - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 99,172 total - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 99,574 total - Sale
Common Stock
2020-05-20$46.77/sh−402$18,802→ 94,348 total - Sale
Common Stock
2020-05-20$46.60/sh−402$18,733→ 93,946 total - Sale
Common Stock
2020-05-20$46.57/sh−402$18,721→ 93,142 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2020-09-02→ Common Stock (402 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2022-08-23→ Common Stock (402 underlying) - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+4,824$149,399→ 97,966 total - Exercise/Conversion
Common Stock
2020-05-20$30.97/sh+402$12,450→ 98,770 total - Sale
Common Stock
2020-05-20$46.51/sh−4,824$224,364→ 94,750 total - Sale
Common Stock
2020-05-20$46.74/sh−402$18,789→ 93,544 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-20$30.97/sh−402$12,450→ 0 totalExercise: $30.97Exp: 2023-09-10→ Common Stock (402 underlying)
Footnotes (1)
- [F1]The stock option is fully vested and immediately exercisable.